US 11,541,080

Application 17/735,743 · Granted Jan 3, 2023

Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

Estimated expiration

August 3, 2031

4y 256d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTAU2011000987: Resource not found (404)
Earliest effective filing
Aug 3, 2011
+ 20 years
Aug 3, 2031
PTA +0d
Aug 3, 2031
TD cap (US 10,675,309)
Aug 3, 2031
Final
Aug 3, 2031

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
May 3, 2022
Earliest effective filing
August 3, 2011
Issue date
January 3, 2023
PTA
0 days
Base expiry (before PTA)
August 3, 2031

August 3, 2011 + 20 years = August 3, 2031

  • Continuation of application 17/496,398, filed Oct 7, 2021, issued as US 11,504,403
  • Continuation of application 16/523,726, filed Jul 26, 2019, issued as US 11,207,356
  • Continuation of application 16/433,437, filed Jun 6, 2019, issued as US 10,463,702
  • Continuation of application 16/364,144, filed Mar 25, 2019, issued as US 10,610,551
  • Continuation of application 16/118,400, filed Aug 30, 2018, issued as US 10,278,997
  • Continuation of application 15/975,456, filed May 9, 2018, issued as US 10,857,188
  • Continuation of application 15/950,939, filed Apr 11, 2018, issued as US 10,064,899
  • Continuation of application 15/782,519, filed Oct 12, 2017, issued as US 9,962,413
  • Continuation of application 15/093,679, filed Apr 7, 2016, issued as US 10,022,406
  • Continuation of application 13/813,915, filed Apr 8, 2013, issued as US 9,308,226
  • National stage entry of application PCTAU2011000987, filed Aug 4, 2011
  • National stage entry of application PCTAU2011000987, filed Aug 3, 2011
  • Continuation of application 13/813,915, filed Apr 8, 2013, issued as US 9,308,226
  • National stage entry of application PCTAU2011000987, filed Aug 4, 2011
  • Continuation of application 15/093,679, filed Apr 7, 2016, issued as US 10,022,406
  • Continuation of application 13/813,915, filed Apr 8, 2013, issued as US 9,308,226
  • National stage entry of application PCTAU2011000987, filed Aug 4, 2011
  • Continuation of application 15/782,519, filed Oct 12, 2017, issued as US 9,962,413
  • Continuation of application 15/093,679, filed Apr 7, 2016, issued as US 10,022,406
  • Continuation of application 13/813,915, filed Apr 8, 2013, issued as US 9,308,226
  • National stage entry of application PCTAU2011000987, filed Aug 4, 2011
  • Continuation of application 15/950,939, filed Apr 11, 2018, issued as US 10,064,899
  • Continuation of application 15/782,519, filed Oct 12, 2017, issued as US 9,962,413
  • Continuation of application 15/093,679, filed Apr 7, 2016, issued as US 10,022,406
  • Continuation of application 13/813,915, filed Apr 8, 2013, issued as US 9,308,226
  • National stage entry of application PCTAU2011000987, filed Aug 4, 2011
  • Continuation of application 15/975,456, filed May 9, 2018, issued as US 10,857,188
  • Continuation of application 15/950,939, filed Apr 11, 2018, issued as US 10,064,899
  • Continuation of application 15/782,519, filed Oct 12, 2017, issued as US 9,962,413
  • Continuation of application 15/093,679, filed Apr 7, 2016, issued as US 10,022,406
  • Continuation of application 13/813,915, filed Apr 8, 2013, issued as US 9,308,226
  • National stage entry of application PCTAU2011000987, filed Aug 4, 2011
  • Continuation of application 16/118,400, filed Aug 30, 2018, issued as US 10,278,997
  • Continuation of application 15/975,456, filed May 9, 2018, issued as US 10,857,188
  • Continuation of application 15/950,939, filed Apr 11, 2018, issued as US 10,064,899
  • Continuation of application 15/782,519, filed Oct 12, 2017, issued as US 9,962,413
  • Continuation of application 15/093,679, filed Apr 7, 2016, issued as US 10,022,406
  • Continuation of application 13/813,915, filed Apr 8, 2013, issued as US 9,308,226
  • National stage entry of application PCTAU2011000987, filed Aug 4, 2011
  • Continuation of application 16/364,144, filed Mar 25, 2019, issued as US 10,610,551
  • Continuation of application 16/118,400, filed Aug 30, 2018, issued as US 10,278,997
  • Continuation of application 15/975,456, filed May 9, 2018, issued as US 10,857,188
  • Continuation of application 15/950,939, filed Apr 11, 2018, issued as US 10,064,899
  • Continuation of application 15/782,519, filed Oct 12, 2017, issued as US 9,962,413
  • Continuation of application 15/093,679, filed Apr 7, 2016, issued as US 10,022,406
  • Continuation of application 13/813,915, filed Apr 8, 2013, issued as US 9,308,226
  • National stage entry of application PCTAU2011000987, filed Aug 4, 2011
  • Continuation of application 16/433,437, filed Jun 6, 2019, issued as US 10,463,702
  • Continuation of application 16/364,144, filed Mar 25, 2019, issued as US 10,610,551
  • Continuation of application 16/118,400, filed Aug 30, 2018, issued as US 10,278,997
  • Continuation of application 15/975,456, filed May 9, 2018, issued as US 10,857,188
  • Continuation of application 15/950,939, filed Apr 11, 2018, issued as US 10,064,899
  • Continuation of application 15/782,519, filed Oct 12, 2017, issued as US 9,962,413
  • Continuation of application 15/093,679, filed Apr 7, 2016, issued as US 10,022,406
  • Continuation of application 13/813,915, filed Apr 8, 2013, issued as US 9,308,226
  • National stage entry of application PCTAU2011000987, filed Aug 4, 2011
  • Continuation of application 16/523,726, filed Jul 26, 2019, issued as US 11,207,356
  • Continuation of application 16/433,437, filed Jun 6, 2019, issued as US 10,463,702
  • Continuation of application 16/364,144, filed Mar 25, 2019, issued as US 10,610,551
  • Continuation of application 16/118,400, filed Aug 30, 2018, issued as US 10,278,997
  • Continuation of application 15/975,456, filed May 9, 2018, issued as US 10,857,188
  • Continuation of application 15/950,939, filed Apr 11, 2018, issued as US 10,064,899
  • Continuation of application 15/782,519, filed Oct 12, 2017, issued as US 9,962,413
  • Continuation of application 15/093,679, filed Apr 7, 2016, issued as US 10,022,406
  • Continuation of application 13/813,915, filed Apr 8, 2013, issued as US 9,308,226
  • National stage entry of application PCTAU2011000987, filed Aug 4, 2011
  • PRO61/450,099 — Provisional — not used for base term
  • PRO61/451,087 — Provisional — not used for base term
  • PRO61/483,487 — Provisional — not used for base term
  • PRO61/494,363 — Provisional — not used for base term
  • PRO61/494,363 — Provisional — not used for base term
  • PRO61/483,487 — Provisional — not used for base term
  • PRO61/451,087 — Provisional — not used for base term
  • PRO61/450,099 — Provisional — not used for base term
  • PRO61/494,363 — Provisional — not used for base term
  • PRO61/483,487 — Provisional — not used for base term
  • PRO61/451,087 — Provisional — not used for base term
  • PRO61/450,099 — Provisional — not used for base term
  • PRO61/494,363 — Provisional — not used for base term
  • PRO61/483,487 — Provisional — not used for base term
  • PRO61/451,087 — Provisional — not used for base term
  • PRO61/450,099 — Provisional — not used for base term
  • PRO61/494,363 — Provisional — not used for base term
  • PRO61/483,487 — Provisional — not used for base term
  • PRO61/451,087 — Provisional — not used for base term
  • PRO61/450,099 — Provisional — not used for base term
  • PRO61/494,363 — Provisional — not used for base term
  • PRO61/483,487 — Provisional — not used for base term
  • PRO61/450,099 — Provisional — not used for base term
  • PRO61/451,087 — Provisional — not used for base term
  • PRO61/494,363 — Provisional — not used for base term
  • PRO61/483,487 — Provisional — not used for base term
  • PRO61/451,087 — Provisional — not used for base term
  • PRO61/450,099 — Provisional — not used for base term
  • PRO61/494,363 — Provisional — not used for base term
  • PRO61/483,487 — Provisional — not used for base term
  • PRO61/451,087 — Provisional — not used for base term
  • PRO61/450,099 — Provisional — not used for base term
  • PRO61/494,363 — Provisional — not used for base term
  • PRO61/483,487 — Provisional — not used for base term
  • PRO61/451,087 — Provisional — not used for base term
  • PRO61/450,099 — Provisional — not used for base term
  • PRO61/494,363 — Provisional — not used for base term
  • PRO61/483,487 — Provisional — not used for base term
  • PRO61/451,087 — Provisional — not used for base term
  • PRO61/450,099 — Provisional — not used for base term
  • PRO61/494,363 — Provisional — not used for base term
  • PRO61/483,487 — Provisional — not used for base term
  • PRO61/451,087 — Provisional — not used for base term
  • PRO61/450,099 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 1 filed

TD caps expiration to August 3, 2031 (earliest expiring referenced patent: US 10,675,309)

  • US 10,675,309· Application 16/703,458Capping patent

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Filing date
    Dec 4, 2019
    Earliest effective filing
    Aug 3, 2011
    Issue date
    Jun 9, 2020
    PTA
    0 days
    Calculated expiration
    Aug 3, 2031

    Continuation of 16/557,283, filed Aug 30, 2019, issued as US 10,617,724

    Continuation of 16/433,437, filed Jun 6, 2019, issued as US 10,463,702

    Continuation of 16/364,144, filed Mar 25, 2019, issued as US 10,610,551

    Continuation of 16/118,400, filed Aug 30, 2018, issued as US 10,278,997

    Continuation of 15/975,456, filed May 9, 2018, issued as US 10,857,188

    Continuation of 15/950,939, filed Apr 11, 2018, issued as US 10,064,899

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    National stage entry of PCTAU2011000987, filed Aug 3, 2011

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 15/950,939, filed Apr 11, 2018, issued as US 10,064,899

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 15/975,456, filed May 9, 2018, issued as US 10,857,188

    Continuation of 15/950,939, filed Apr 11, 2018, issued as US 10,064,899

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 16/118,400, filed Aug 30, 2018, issued as US 10,278,997

    Continuation of 15/975,456, filed May 9, 2018, issued as US 10,857,188

    Continuation of 15/950,939, filed Apr 11, 2018, issued as US 10,064,899

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 16/523,726, filed Jul 26, 2019, issued as US 11,207,356

    Continuation of 16/433,437, filed Jun 6, 2019, issued as US 10,463,702

    Continuation of 16/364,144, filed Mar 25, 2019, issued as US 10,610,551

    Continuation of 16/118,400, filed Aug 30, 2018, issued as US 10,278,997

    Continuation of 15/975,456, filed May 9, 2018, issued as US 10,857,188

    Continuation of 15/950,939, filed Apr 11, 2018, issued as US 10,064,899

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 16/364,144, filed Mar 25, 2019, issued as US 10,610,551

    Continuation of 16/118,400, filed Aug 30, 2018, issued as US 10,278,997

    Continuation of 15/975,456, filed May 9, 2018, issued as US 10,857,188

    Continuation of 15/950,939, filed Apr 11, 2018, issued as US 10,064,899

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 16/523,726, filed Jul 26, 2019, issued as US 11,207,356

    Continuation of 16/433,437, filed Jun 6, 2019, issued as US 10,463,702

    Continuation of 16/364,144, filed Mar 25, 2019, issued as US 10,610,551

    Continuation of 16/118,400, filed Aug 30, 2018, issued as US 10,278,997

    Continuation of 15/975,456, filed May 9, 2018, issued as US 10,857,188

    Continuation of 15/950,939, filed Apr 11, 2018, issued as US 10,064,899

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Aug 3, 2011 + 20y = Aug 3, 2031

  • US 10,463,702· Application 16/433,437

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Filing date
    Jun 6, 2019
    Earliest effective filing
    Aug 3, 2011
    Issue date
    Nov 5, 2019
    PTA
    0 days
    Calculated expiration
    Aug 3, 2031

    Continuation of 16/364,144, filed Mar 25, 2019, issued as US 10,610,551

    Continuation of 16/118,400, filed Aug 30, 2018, issued as US 10,278,997

    Continuation of 15/975,456, filed May 9, 2018, issued as US 10,857,188

    Continuation of 15/950,939, filed Apr 11, 2018, issued as US 10,064,899

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    National stage entry of PCTAU2011000987, filed Aug 3, 2011

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 15/950,939, filed Apr 11, 2018, issued as US 10,064,899

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 15/975,456, filed May 9, 2018, issued as US 10,857,188

    Continuation of 15/950,939, filed Apr 11, 2018, issued as US 10,064,899

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Continuation of 16/118,400, filed Aug 30, 2018, issued as US 10,278,997

    Continuation of 15/975,456, filed May 9, 2018, issued as US 10,857,188

    Continuation of 15/950,939, filed Apr 11, 2018, issued as US 10,064,899

    Continuation of 15/782,519, filed Oct 12, 2017, issued as US 9,962,413

    Continuation of 15/093,679, filed Apr 7, 2016, issued as US 10,022,406

    Continuation of 13/813,915, filed Apr 8, 2013, issued as US 9,308,226

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Aug 3, 2011 + 20y = Aug 3, 2031

  • US 9,308,226· Application 13/813,915

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Filing date
    Apr 8, 2013
    Earliest effective filing
    Aug 4, 2011
    Issue date
    Apr 12, 2016
    PTA
    0 days
    Calculated expiration
    Aug 4, 2031

    National stage entry of PCTAU2011000987, filed Aug 4, 2011

    Aug 4, 2011 + 20y = Aug 4, 2031

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/735,743 · US 11,541,080

PatentReply compiles the prosecution history behind US 11,541,080: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US11541080

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.